🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested
This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-08-09
Trial ID
NCT04526288
This phase II trial studies the effect of adding pomalidomide to usual chem...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-08-24
Trial ID
NCT04802161
This phase I trial studies the best dose and side effects of liposomal cyta...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-05-21
Trial ID
NCT04915612
Treatments Being Tested
This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2021-07-29
Trial ID
NCT04269213
Treatments Being Tested
This phase 2 clinical trial studies how well CPX-351 (liposomal cytarabine-...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2014-02-03
Trial ID
NCT02019069
Treatments Being Tested
To assess the impact of moderate hepatic impairment on cytarabine and dauno...
Status
Withdrawn
Location
Ronald Reagan UCLA Medical Center
Start Date
2015-04
Trial ID
NCT02269579
Treatments Being Tested
Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2017-07-07
Trial ID
NCT03226418
This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-10-29
Trial ID
NCT03629171
Treatments Being Tested
This phase II trial studies the side effects and how well liposome-encapsul...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-11-07
Trial ID
NCT03672539
Treatments Being Tested